References

  1. Chabbert-Buffet N, Seroussi B, Chopier J, Fajac A, Antoine M, Boucher C et al. Modalités de fonctionnement d'un centre de suivi des femmes à haut risque de cancer du sein et de l'ovaire : une expérience à l'hôpital Tenon Modalities for the functionning of a Care Center for women at high risk for breast and ovarian cancers: the French experience of Tenon Hospital. Gynécologie Obstétrique & Fertilité. 2010; Volume 38(3): pages 183-192. Google Scholar

  2. Chompret A. Diagnostic génétique du cancer du sein et de l'ovaire héréditaire. Journal de Gynécologie Obstétrique et Biologie de la Reproduction. 2003; 32(2):101-119. Google Scholar

  3. François Eisinger, Brigitte Bressac, Damienne Castaigne, Pierre-Henri Cottu, Jacques Lansac, Jean-Pierre Lefranc, Anne Lesur, Catherine Noguès, Janine Pierret, Séverine Puy-Pernias, Hagay Sobol, Anne Tardivon, Henri Tristant, Richard Villet. Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour Mars 2004). John Libbey Eurotext. 2004; Volume 91(3):219-37. Google Scholar

  4. Han X, Jemal A. Recent Patterns in Genetic Testing for Breast and Ovarian Cancer Risk in the US. Am J Prev Med. oct 2017; 53(4):504-7. Google Scholar

  5. Schneider J, Lahl J, Kramer W. Long-term breast cancer risk following ovarian stimulation in young egg donors: a call for follow-up, research and informed consent. Reprod Biomed Online. Mai 2017;34(5):480-5. PubMed | Google Scholar

  6. Schrauder MG, Brunel-Geuder L, Häberle L, Wunderle M, Hoyer J, Reis A et al. Cost-effectiveness of risk-reducing surgeries in preventing hereditary breast and ovarian cancer. Breast Edinb Scotl. Avr 2017;32:186-91. PubMed | Google Scholar

  7. Senkus E, Szade J, Pieczyńska B, Żaczek A, Pikiel J, Sosińska-Mielcarek K et al. Are synchronous and metachronous bilateral breast cancers different? an immunohistochemical analysis aimed at intrinsic tumor phenotype. Int J Clin Exp Pathol. 15 Déc 2013;7(1):353-63. PubMed | Google Scholar

  8. Peters ML, Garber JE, Tung N. Managing hereditary breast cancer risk in women with and without ovarian cancer. Gynecol Oncol. 2017; 146(1):205-14. PubMed | Google Scholar

  9. Song J-L, Chen C, Yuan J-P, Li J-J, Sun S-R. Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosis. Breast Edinb Scotl. Avr 2017;32:130-4. PubMed | Google Scholar